questionsmedicales.fr
Systèmes sanguin et immunitaire
Système immunitaire
Phagocytes
Macrophages
Cellules spumeuses
Cellules spumeuses : Questions médicales fréquentes
Termes MeSH sélectionnés :
Attention Deficit Disorder with Hyperactivity
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cellules spumeuses : Questions médicales les plus fréquentes",
"headline": "Cellules spumeuses : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cellules spumeuses : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-24",
"dateModified": "2025-04-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cellules spumeuses"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Macrophages",
"url": "https://questionsmedicales.fr/mesh/D008264",
"about": {
"@type": "MedicalCondition",
"name": "Macrophages",
"code": {
"@type": "MedicalCode",
"code": "D008264",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A15.382.680.397"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Cellules spumeuses",
"alternateName": "Foam Cells",
"code": {
"@type": "MedicalCode",
"code": "D005487",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Maria Kurańska",
"url": "https://questionsmedicales.fr/author/Maria%20Kura%C5%84ska",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry and Technology of Polymers, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland."
}
},
{
"@type": "Person",
"name": "Aleksander Prociak",
"url": "https://questionsmedicales.fr/author/Aleksander%20Prociak",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry and Technology of Polymers, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland."
}
},
{
"@type": "Person",
"name": "Aniket Raje",
"url": "https://questionsmedicales.fr/author/Aniket%20Raje",
"affiliation": {
"@type": "Organization",
"name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany."
}
},
{
"@type": "Person",
"name": "Joachim Koll",
"url": "https://questionsmedicales.fr/author/Joachim%20Koll",
"affiliation": {
"@type": "Organization",
"name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany."
}
},
{
"@type": "Person",
"name": "Jelena Lillepärg",
"url": "https://questionsmedicales.fr/author/Jelena%20Lillep%C3%A4rg",
"affiliation": {
"@type": "Organization",
"name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Attachment in adolescents with attention deficit hyperactivity disorder and oppositional defiant disorder.",
"datePublished": "2022-06-30",
"url": "https://questionsmedicales.fr/article/36342984",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12740/PP/OnlineFirst/130366"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of Personality Disorders in Adults With Attention Deficit Hyperactivity Disorder (ADHD).",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36927130",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10870547231161531"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder in Individuals with Autism Spectrum Disorder.",
"datePublished": "2022-05-11",
"url": "https://questionsmedicales.fr/article/35697395",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chc.2022.03.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pragmatic Deficits in Attention Deficit/Hyperactivity Disorder: Systematic Review and Meta-Analysis.",
"datePublished": "2023-03-28",
"url": "https://questionsmedicales.fr/article/36975307",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10870547231161534"
}
},
{
"@type": "ScholarlyArticle",
"name": "Oculomotor deficits in attention deficit hyperactivity disorder: a systematic review and meta-analysis.",
"datePublished": "2022-10-24",
"url": "https://questionsmedicales.fr/article/36280758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-022-02284-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Systèmes sanguin et immunitaire",
"item": "https://questionsmedicales.fr/mesh/D006424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007107"
},
{
"@type": "ListItem",
"position": 4,
"name": "Phagocytes",
"item": "https://questionsmedicales.fr/mesh/D010586"
},
{
"@type": "ListItem",
"position": 5,
"name": "Macrophages",
"item": "https://questionsmedicales.fr/mesh/D008264"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cellules spumeuses",
"item": "https://questionsmedicales.fr/mesh/D005487"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cellules spumeuses - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cellules spumeuses",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cellules spumeuses",
"description": "Comment diagnostique-t-on les cellules spumeuses ?\nQuels tests sont utilisés pour détecter les cellules spumeuses ?\nLes cellules spumeuses sont-elles visibles à l'échographie ?\nQuel rôle joue la biopsie dans le diagnostic ?\nPeut-on détecter les cellules spumeuses par analyse sanguine ?",
"url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cellules spumeuses",
"description": "Quels symptômes sont associés aux cellules spumeuses ?\nLes cellules spumeuses causent-elles des douleurs ?\nComment les cellules spumeuses affectent-elles la circulation ?\nY a-t-il des signes cliniques visibles ?\nLes cellules spumeuses sont-elles liées à des maladies spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cellules spumeuses",
"description": "Comment prévenir la formation de cellules spumeuses ?\nLe tabagisme influence-t-il les cellules spumeuses ?\nLe stress a-t-il un impact sur les cellules spumeuses ?\nUne alimentation riche en graisses est-elle risquée ?\nL'exercice régulier aide-t-il à prévenir les cellules spumeuses ?",
"url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cellules spumeuses",
"description": "Quels traitements ciblent les cellules spumeuses ?\nLes statines aident-elles contre les cellules spumeuses ?\nY a-t-il des traitements non médicamenteux ?\nLes interventions chirurgicales sont-elles nécessaires ?\nLes traitements naturels sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cellules spumeuses",
"description": "Quelles complications sont liées aux cellules spumeuses ?\nLes cellules spumeuses augmentent-elles le risque d'AVC ?\nPeuvent-elles causer des douleurs thoraciques ?\nLes cellules spumeuses sont-elles réversibles ?\nY a-t-il des risques de rupture de plaque ?",
"url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cellules spumeuses",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la formation de cellules spumeuses ?\nLe cholestérol élevé est-il un facteur de risque ?\nLe diabète affecte-t-il la santé vasculaire ?\nLe manque d'exercice est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on les cellules spumeuses ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'analyse histologique des tissus vasculaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les cellules spumeuses ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des biopsies et des examens d'imagerie comme l'IRM peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les cellules spumeuses sont-elles visibles à l'échographie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles ne sont généralement pas visibles à l'échographie standard."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biopsie dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet d'observer la présence de cellules spumeuses dans les plaques."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les cellules spumeuses par analyse sanguine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles sont principalement détectées dans les tissus, pas dans le sang."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux cellules spumeuses ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cellules spumeuses elles-mêmes ne provoquent pas de symptômes directs."
}
},
{
"@type": "Question",
"name": "Les cellules spumeuses causent-elles des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles ne causent pas de douleurs, mais contribuent à des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment les cellules spumeuses affectent-elles la circulation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent obstruer les vaisseaux sanguins, entraînant des problèmes circulatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les cellules spumeuses ne présentent pas de signes cliniques visibles."
}
},
{
"@type": "Question",
"name": "Les cellules spumeuses sont-elles liées à des maladies spécifiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent associées à l'athérosclérose et aux maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment prévenir la formation de cellules spumeuses ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain avec une alimentation équilibrée et de l'exercice."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les cellules spumeuses ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de formation de cellules spumeuses et d'athérosclérose."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les cellules spumeuses ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut contribuer à des maladies cardiovasculaires, y compris les cellules spumeuses."
}
},
{
"@type": "Question",
"name": "Une alimentation riche en graisses est-elle risquée ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées favorise la formation de cellules spumeuses."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à prévenir les cellules spumeuses ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la santé cardiovasculaire et réduit les risques."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les cellules spumeuses ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements visent à réduire le cholestérol et à prévenir l'athérosclérose."
}
},
{
"@type": "Question",
"name": "Les statines aident-elles contre les cellules spumeuses ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les statines réduisent le cholestérol et limitent la formation de cellules spumeuses."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine et l'exercice physique peuvent aider à prévenir leur formation."
}
},
{
"@type": "Question",
"name": "Les interventions chirurgicales sont-elles nécessaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être nécessaires en cas de complications graves, comme une occlusion."
}
},
{
"@type": "Question",
"name": "Les traitements naturels sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains compléments peuvent aider, mais leur efficacité n'est pas prouvée scientifiquement."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées aux cellules spumeuses ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des maladies cardiovasculaires graves, comme l'infarctus."
}
},
{
"@type": "Question",
"name": "Les cellules spumeuses augmentent-elles le risque d'AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent contribuer à l'athérosclérose, augmentant le risque d'AVC."
}
},
{
"@type": "Question",
"name": "Peuvent-elles causer des douleurs thoraciques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en provoquant des maladies cardiaques qui peuvent entraîner des douleurs."
}
},
{
"@type": "Question",
"name": "Les cellules spumeuses sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une fois formées, elles ne sont pas réversibles, mais leur progression peut être contrôlée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de rupture de plaque ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les cellules spumeuses peuvent contribuer à la rupture de plaques athéroscléreuses."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'hypertension, le diabète et l'obésité."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la formation de cellules spumeuses ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge en raison de l'accumulation de lipides."
}
},
{
"@type": "Question",
"name": "Le cholestérol élevé est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un taux de cholestérol élevé favorise la formation de cellules spumeuses."
}
},
{
"@type": "Question",
"name": "Le diabète affecte-t-il la santé vasculaire ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète augmente le risque de maladies cardiovasculaires et de cellules spumeuses."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire augmente le risque de formation de cellules spumeuses."
}
}
]
}
]
}
To assess attachment styles among adolescents (13-16 years) with ADHD or ADHD and oppositional defiant disorders (ODD)....
The Parents and Peers Attachment (IPPA) and the Parent Bonding Questionnaire (PBI) were used in three groups of teenagers raised in biological families: (1) ADHD/ODD group (n = 40), (2) ADHD group (n ...
Parental attachment styles in the area of "Trust", "Communication" and "Alienation" (IPPA), and "Care" and "Control" (PBI) in the ADHD/ODD group differ significantly compared to the control group. Tee...
The attachment style is significantly different in adolescents diagnosed with ADHD and ODD than in adolescents with only ADHD. In the ADHD/ODD group and the ADHD group, unlike in the group of adolesce...
To estimate the prevalence of PDs according to Millon's evolution-based model among adult ADHD outpatients....
Cross-sectional study of consecutive patients referred to an adult ADHD clinic. PDs were evaluated with Millon Clinical Multiaxial Inventory-III (MCMI-III)....
One-hundred-eighty-one participants had valid MCMI-III, of whom147 were diagnosed with ADHD. Mean age: 32.97, SD:11.56, females: 74 (50.3%). Among the 147 participants with ADHD, 29 (19.7%) did not me...
Particular personality profiles were more common with different ADHD subtypes. Given the developmental origins of PD, further research may help identify possible links with childhood difficulties....
Attention-deficit/hyperactivity disorder (ADHD) is the most frequent comorbid disorder that is observed at a higher rate and with greater morbidity in higher intellectually functioning populations wit...
While poorer pragmatic language skills have been found in attention-deficit/hyperactivity disorder (ADHD) populations, there has been no conclusive evidence of this. We aimed to conduct a meta-analysi...
Studies were identified using the search terms ((attention deficit) OR (adhd)) AND (pragmatics), and those studies were screened and reviewed for inclusion criteria, descriptive information, and outco...
A total of 14 studies (5,772 participants) met the criteria for quantitative synthesis. Meta-analysis indicated that ADHD populations exhibited significantly poorer pragmatic language skills than TD p...
It is suggested that pragmatic language skills may deserve greater surveillance considering the importance of pragmatic language in socio-emotional development, daily life, and academic success....
There is equivocal evidence on the presence of oculomotor deficits among children with attention deficit hyperactivity disorder (ADHD), which can be an additional challenge in this population, especia...
Emerging evidence implicate the gut microbiota as a potential susceptibility factor in attention-deficit hyperactivity disorder (ADHD), a common multifactorial neurodevelopmental condition. However, l...
Comorbidities are common in children with epilepsy, with nearly half of the patients having at least one comorbidity. Attention deficit hyperactivity disorder (ADHD) is a psychiatric disorder characte...
Rates of cannabis use have been rising in the US due to the increasing legalization/decriminalization of cannabis products for medical and recreational use. Individuals with attention-deficit hyperact...
People with attention deficit and hyperactivity disorder (ADHD) present attentional and emotional deficits and show paradoxical qualities such as hyperfocus. Previous studies have reported errors, slo...
Thirty French children and teenagers, 15 with ADHD and 15 neurotypical (NT), underwent a saccadic eye movement task. We conducted conventional analysis (movement duration, precision, velocity, RT) and...
Saccade duration and velocity failed to differentiate the two groups, whereas amplitude was higher in ADHD than in NT participants. Saccade RT and variability were higher in ADHD than in NT participan...
ADHD disrupts two mechanisms of action: it reduces the gain of the decision signal, thus explaining slowness and variability; it quickens the decision process of early responses at the origin of short...
These premises and their interconnections explain previous observations and support the striatal-frontal wiring of ADHD, thus explaining ADHD complexity in its negative and positive manifestations....
The association between attention-deficit/hyperactivity disorder (ADHD) and schizophrenia has received increased attention; however, evidence on the association between psychiatric comorbidities and s...
To investigate the risk of being diagnosed with schizophrenia in children and adolescents with ADHD considering the presence of psychiatric comorbidity....
This was a population-based, retrospective cohort study using the Health Insurance Review and Assessment claims database from January 1, 2007, to December 31, 2019. Participants were children and adol...
The presence of psychiatric comorbidity was assessed from diagnosis records within 1 year before ADHD diagnosis. Comorbidities were further categorized according to the number of comorbidities and spe...
Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CIs, examining the association between psychiatric comorbidities and the risk of being diagnosed with schizophrenia. Fu...
A total of 211 705 patients with newly diagnosed ADHD were included. A total of 157 272 patients (74.3%) were male, and the age of 5 to 9 years showed the highest distribution (115 081 patients [54.4%...
In this retrospective cohort study involving children and adolescents with ADHD, the presence of psychiatric comorbidity in patients with ADHD was associated with an increased risk of being diagnosed ...